A Dose Calibration Study Comparing IkT-001Pro to Imatinib Mesylate 400mg
Clinical trial NCT05623774 · COMPLETED
Trial details
- NCT number
- NCT05623774
- Sponsor
- Inhibikase Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-16
- Primary completion
- 2024-06-30
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.